---
figid: PMC9694790__nutrients-14-04768-g004
figtitle: Advances in Fucoxanthin Research for the Prevention and Treatment of Inflammation-Related
  Diseases
organisms:
- Mus musculus
- Rattus norvegicus
- Sargassum siliquastrum
- Conticribra weissflogii
- Punica granatum
- Chaetoceros calcitrans
- Phaeodactylum tricornutum
- Phaeophyceae
- Tetranychus urticae
- Fucus vesiculosus
- PX clade
- Endarachne binghamiae
- Saccharina japonica
- Homo sapiens
- NA
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9694790
filename: nutrients-14-04768-g004.jpg
figlink: /pmc/articles/PMC9694790/figure/nutrients-14-04768-f004/
number: F4
caption: Pathway underlying the anti-tumor and anti-cancer effects of fucoxanthin
  (FX). FX achieves its anti-tumor effects by inhibiting inflammatory pathways such
  as NF-κB, MAPK, JAK-STAT, and PI3K/AKT. The expression level of GADD45α and the
  BAX/BCL2 ratio increased, and the expression of related cell cycle proteins, such
  as CDK2/4/6, Bcl-2, XIAP, and CIAP1/2, decreased after the related inflammatory
  pathways were inhibited by FX, which led to the regulation of apoptosis and cell
  cycle arrest, thus controlling tumor and cancer development and progression.
papertitle: Advances in Fucoxanthin Research for the Prevention and Treatment of Inflammation-Related
  Diseases.
reftext: Biyun Guan, et al. Nutrients. 2022 Nov;14(22):4768.
year: '2022'
doi: 10.3390/nu14224768
journal_title: Nutrients
journal_nlm_ta: Nutrients
publisher_name: MDPI
keywords: fucoxanthin | anti-inflammatory | antioxidant | anti-tumor | anti-obesity
automl_pathway: 0.9007981
figid_alias: PMC9694790__F4
figtype: Figure
redirect_from: /figures/PMC9694790__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9694790__nutrients-14-04768-g004.html
  '@type': Dataset
  description: Pathway underlying the anti-tumor and anti-cancer effects of fucoxanthin
    (FX). FX achieves its anti-tumor effects by inhibiting inflammatory pathways such
    as NF-κB, MAPK, JAK-STAT, and PI3K/AKT. The expression level of GADD45α and the
    BAX/BCL2 ratio increased, and the expression of related cell cycle proteins, such
    as CDK2/4/6, Bcl-2, XIAP, and CIAP1/2, decreased after the related inflammatory
    pathways were inhibited by FX, which led to the regulation of apoptosis and cell
    cycle arrest, thus controlling tumor and cancer development and progression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nfkb1
  - Pik3r1
  - Akt1
  - Gadd45a
  - Bcl2
  - Bax
  - Nkx3-1
  - Birc3
  - Birc2
  - Bc1
  - Bc1-ps1
  - Igkv1-136
  - Xiap
  - Cdk4
  - Cdk6
  - Cdk2
  - Gabrg2
  - Pik3cg
  - Defb1
  - Ccne1
  - NFKB1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - GADD45A
  - BCL2
  - BAX
  - BIRC2
  - CHMP2A
  - XIAP
  - CDK4
  - CDK6
  - CDK2
  - WARS1
  - Dif
  - dl
  - Rel
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - hop
  - bsk
  - Stat92E
  - MKP-4
  - p38b
  - rl
  - Debcl
  - bc2
  - BC1
  - CycE
  - cyc
  - anon-70Dc
  - Fucoxanthin
---
